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regulate p21 expression. A new molecular mechanism has been identiﬁed where Tbx1 inhibits Pitx2
transcriptional activity and decreases the expression of Pitx2 target genes, p21, Lef-1 and Pitx2c. p21 protein is
increased in PITX2C transgenic mouse embryo ﬁbroblasts (MEF) and chromatin immunoprecipitation assays
demonstrate endogenous Pitx2 binding to the p21 promoter. Tbx1 attenuates PITX2 activation of endogenous
p21 expression and Tbx1 null MEFs reveal increased Pitx2a and activation of Pitx2c isoform expression. Tbx1
physically interacts with the PITX2 C-terminus and represses PITX2 transcriptional activation of the p21, LEF-1,
and Pitx2c promoters. Tbx1−/+/Pitx2−/+ double heterozygous mice present with an extra premolar-like tooth
revealing a genetic interaction between these factors. The ability of Tbx1 to repress PITX2 activation of p21may
promote cell proliferation. In addition, PITX2 regulation of p21 reveals a new role for PITX2 in repressing cell
proliferation. These data demonstrate new functionalmechanisms for Tbx1 in toothmorphogenesis andprovide a
molecular basis for craniofacial defects in DiGeorge syndrome patients.ter, Institute of Biosciences and
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DiGeorge syndrome is themost common genetic deletion syndrome
in humans. It is a complex developmental disorder associated with
congenital heart disease, craniofacial abnormalities, thymic and
parathyroid defects (Dodson et al., 1969; Goldberg et al., 1993;
Shprintzen et al., 1978). Many of the structures affected in this
syndrome are derived from the pharyngeal system. Through chromo-
some engineering, gene targeting in mice (Jerome and Papaioannou,
2001; Lindsay et al., 1999, 2001; Merscher et al., 2001) and mutation
screen in human patients (Paylor et al., 2006; Yagi et al., 2003), TBX1has
been associated with this syndrome. Tbx1 homozygous loss-of-function
mice recapitulate most, if not all, of the pharyngeal system derived
defects associated with DiGeorge syndrome. Many human syndromes
such as DiGeorge and Axenfeld–Rieger syndrome (ARS) that have toothdefects also have heart and other defects (Fukui et al., 2000; Hjalt and
Semina, 2005). The molecular mechanisms of Tbx1 in tooth and
craniofacial development are the focus of this study.
T-box factors (like Tbx1) are transcription factors containing a
conserved DNA binding domain termed the T-box, a 180 amino acid
DNA binding domain (Bollag et al., 1994; Naiche et al., 2005). The ﬁrst
T-box factor identiﬁedwas Brachyury and there are now17members of
the T-boxmembers identiﬁed in humans andmice (Naiche et al., 2005).
T-box factors are involved in many developmental processes and
signaling pathways including heart and tooth development. T-box
factors can activate or repress transcription and some contain both
activation and repression domains in their C-terminal tails (Kispert,
1995; Stennard et al., 2003). Furthermore, T-box factors interact with
other transcription factors to regulate gene expression (Naiche et al.,
2005).
The tooth development process is an excellent model to study
molecularmechanisms involved in organogenesis. This process involves
sequential and reciprocal interaction between the oral ectoderm and
neural crest derived mesenchyme (Thesleff and Sharpe, 1997). Tooth
development proceeds through a series of stages startingwith initiation
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Alappat et al., 2005; Peters and Balling, 1999; Thesleff, 2003; Tucker and
Sharpe, 2004). The invaginating (ectoderm) tooth bud encircles the
condensing (neural crest) mesenchyme. A transient primary enamel
knot appears in the dental epithelium,whichmarks the bud to cap stage
(E14–15) transition. The inner dental epithelium derived pre-amelo-
blasts later differentiate into enamel secreting ameloblasts. During bell
stage (E16–18) the inner dental epithelium and the dental papilla are
juxtapositioned and, separated by a basement membrane. The inner
dental epithelium and the basement membrane regulate the differen-
tiation of odontoblasts (Lesot et al., 2001). This differentiation is
initiated where the dental epithelium folds to form enamel knot
structures (Bei et al., 2000; Thesleff et al., 2001). The enamel knots are
signaling centers that regulate tooth morphogenesis and molar cusp
patterns (Jernvall et al., 1994; Thesleff et al., 2001). Furthermore, p21 a
cyclin-dependent kinase inhibitor is expressed in the dental epithelium
and enamel knot and is known to inhibit cell proliferation (Jernvall et al.,
1998;Weber et al., 2008). However, the transcription factors regulating
p21 expression nor are the molecular mechanisms of p21 in regulating
epithelial cell proliferation and differentiation known.
The cervical loop comprises a region of the lingual and labial
epithelium that contain progenitor cells giving rise to four cell
lineages; the inner enamel epithelium, stratum intermedium, stellate
reticulum and the outer enamel epithelium (Harada et al., 1999;
Harada and Ohshima, 2004; Harada et al., 2002). The cervical loop
structures are present in bothmolars and incisors and are required for
the proliferation, differentiation and growth of both types of teeth.
The apical end of the rodent incisor or “apical bud” has been proposed
to be a special epithelial component for the stem cell niche that gives
rise to progenitor cells of the cervical loop (Harada and Ohshima,
2004). These cells then populate the incisor and molar tooth germs
and proliferate and differentiate in a gradient from less differentiated
at the lingual side to the fully differentiated cells at the labial side as
morphogenesis progresses. The molecular mechanisms controlling
the proliferation and differentiation of cells in the cervical loops are
not known as well as the transcription factors involved in this process.
Because Tbx1 has an important role during development of
pharyngeal system derivatives, we wanted to determine the molecular
mechanisms of Tbx1 function during tooth development. Tbx1 expres-
sion has been reported in incisors and molars throughout the dental
epithelium including the cervical loop and enamel knot (Caton et al.,
2009; Mitsiadis et al., 2008; Zoupa et al., 2006). We report that Tbx1
homozygous loss-of-function mice have defective dental progenitor
epithelial cells proliferation. The proliferation defects are associated
with an increase in p21 expression in the dental epitheliumand cervical
loop. Pitx2, a homeobox transcription factor and Tbx1 expression
patterns overlap during tooth development. Pitx2 activates endogenous
p21 expression, which is antagonized by Tbx1. Tbx1 physically interacts
with PITX2 to repress PITX2 transcriptional activity and PITX2 target
genes. Interestingly, Tbx1 inhibits the endogenous auto-regulation of
the Pitx2c isoform by Pitx2a. A genetic interaction between these two
factors was revealed in the Tbx1−/+/Pitx2−/+ heterozygous mice with
the development of an extra premolar-like tooth. These data provide
new molecular mechanisms for Tbx1 and Pitx2 in regulating dental
progenitor cell proliferation and tooth morphogenesis.
Materials and methods
Animals
Heterozygous Tbx1mice carrying the lacZ knock-in allele Tbx1tm1Bld
(here referred to as Tbx1+/−) were obtained as described previously
(Lindsay et al., 2001). Mutants were maintained and analyzed on a
C57BL/6-129SvEvBrd (129S5) mixed genetic background and were
crossed to each other orwild typemice of the same genetic background.
The Pitx2−/− mice have been previously reported (Lu et al., 1999) andmaintained and analyzed on a C57BL/6-129SvEvBrd (129S5) mixed
genetic background andwere crossed to each other orwild typemice of
the same genetic background. The K14-PITX2C transgenic mice have
been reported (Venugopalan et al., 2008). MEFs were obtained from
E14.5 mutant and transgenic mice embryos. Embryos were collected at
various time points, considering the day of observation of a vaginal plug
to be embryonic day (E) 0.5. Mice and embryos were genotyped by PCR
of DNA extracted from tail biopsies or yolk sacs, respectively using
previously published PCR primer pairs (Lindsay et al., 2001).
Histology
Mouse embryos or heads were dissected in phosphate-buffered
saline (PBS), and ﬁxed with 4% paraformaldehyde-PBS solution for
4 h. Following ﬁxation, samples were dehydrated through graded
ethanol, embedded in parafﬁn wax and sectioned (7 μm). Sections
were stained with Hematoxylin and Eosin. All sections were
visualized using a Nikon Eclipse 80i microscope with low noise
ﬂuorescence imaging capability or a Nikon SMZ800 Stereomicroscope
with imaging. All image acquisition and analyses were done using an
imaging workstation with NIS-Elements.
Detection of β-galactosidase (LacZ) activities
Whole embryos or heads were stained for β-galactosidase activity
according to standard procedures. Embryos were ﬁxed for 30–60 min
at RT in 0.2% glutaraldehyde in PBS. Fixed embryos werewashed three
times in rinse solution (0.005% Nonidet P-40 and 0.01% sodium
deoxycholate in PBS) and stained overnight at room temperature
using standard staining solution (5 mMpotassium ferricyanide, 5 mM
potassium ferrocyanide, 2 mM MgCl2, 0.4% X-gal in PBS). The next
morning, samples were rinsed in PBS and then photographed. After
that, samples were post-ﬁxed in 4% formaldehyde, they were
dehydrated through graded ethanol, embedded in parafﬁn wax and
sectioned. Sections were cut at 12-μm thickness and lightly counter-
stained with eosin.
Immunohistochemistry
Tissue was prepared by 4% formaldehyde ﬁxation of whole
embryos or heads, which were parafﬁn wax embedded and sectioned
at a thickness of 7 μm. The antigens were retrieved by autoclaving in
Tris–HCl buffer (pH 9.0) for 5 min. Rabbit anti-P21 (Santa Cruz) was
diluted 1:50 in TBS/0.1% Triton X-100/5% goat serum/1% BSA, Rabbit
anti-AMELOGENIN (Santa Cruz) was diluted 1:500 in TBS/0.1% Triton
X-100/5% goat serum/1% BSA. Primary antibody incubated overnight
at 4 °C and detected with a biotinylated goat anti-rabbit IgG conjugate
(1:200; Vector lab), avidin–biotin complex formation (Vector lab) and
AEC Staining Kit (Sigma).
BrdU labeling
BrdU was injected into the pregnant mouse (50 μg/g of body
weight) 2 h prior to harvesting embryos. Samples were embedded as
described above. Sections were incubated for 5 min in 3% H2O2,
microwaved 10 min in 10 mM Citrate Buffer (pH 6.0), hydrolyzed for
60 min in 2 N HCl, neutralized for 10 min in 0.1 M sodium borate,
rinsed, blocked for 1 h in 10% goat serum, and immunostained with
rat anti-BrdU antibody (1:250, Abcam). Tbx1−/− and wild type
sections were placed on the same slide and processed together and
equally for identical time periods. We sectioned two separate
embryos for each genotype. For every 10 sections we collected two
serial sections for BrdU and H&E staining, respectively. For quantita-
tion we count at least 3 sections from each embryo.
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β-galactosidase assays
The Tbx1 expression plasmid has been previously described (Xu et al.,
2004). The PITX2 plasmids have been previously described (Amen et al.,
2007). The human LEF-1 and p21 promoters have been previously
described (Nakano et al., 1997; Vadlamudi et al., 2005). The 3.0 kbmouse
Pitx2c 5′ ﬂanking genomic sequencewas cloned into the luciferase vector
using HindIII and BamH1 restriction enzymes. CHO and LS-8 cells (Chen
et al., 1992) were cultured in DMEM supplemented with 5% or 10% fetal
bovine serum (FBS) and penicillin/streptomycin and transfected by
electroporation. Cultureswere fed 24 h prior to transfection, resuspended
in PBS and mixed with 2.5 μg of expression plasmids, 5 μg of reporter
plasmid and 0.5 μg of SV-40 β-galactosidase plasmid. Electroporation of
CHOcellswereperformedat360 Vand950 microfarads (μF) (GenePulser
XL, Bio-Rad). LS-8 cells were transfected by electroporation as previously
described (Green et al., 2001). Transfected cellswere incubated for 24 h in
60 mmculturedishesand fedwith10%FBSandDMEMandthen lysedand
assayed for reporter activities and protein content by Bradford assay
(Bio-Rad). Luciferase was measured using reagents from Promega.
β-Galactosidase was measured using the Galacto-Light Plus reagents
(Tropix Inc.). All luciferase activities were normalized to β-galactosidase
activity. All plasmids were double-banded CsCl puriﬁed.
Expressions of endogenous or transiently expressed PITX2, and
Tbx1 proteins were demonstrated using the PITX2 P2R10 antibody
(Hjalt et al., 2000), or Tbx1 antibodies (Zymed). Approximately
10–40 μg of transfected cell lysates were analyzed in Western blots.
Following SDS gel electrophoresis, the proteins were transferred to
PVDF ﬁlters (Millipore), immunoblotted and detected using speciﬁc
antibodies and ECL reagents from GE HealthCare.
Immunoprecipitation assays
Approximately 24 h after cell transfection with Tbx1 and PITX2, CHO
cellswere rinsedwith 1 ml of PBS, and then incubatedwith1 ml ice cold
RIPA buffer for 15 m at 4 °C. Cells were harvested and disrupted by
repeated aspiration through a 25-gauge needle attached to a 1 ml
syringe. The lysates were then incubated on ice for 30 min. Cellular
debris was pelleted by centrifugation at 10,000 ×g for 10 min at 4 °C. An
aliquot of lysatewas saved for analysis as input control. Supernatantwas
transferred to a fresh1.5 mlmicrofuge tube on ice and pre-cleared using
the Pre-clearing Matrix C-mouse (ExactaCruz C, Santa Cruz Biotechnol-
ogy) for 30 min at 4 °C. Matrixwas removed by brief centrifugation and
supernatant transferred to a new tube. An IP antibody–IP matrix
complexwasprepared as permanufacturer's instructionsusingprimary
anti-Tbx1 antibody (Zymed). The IP antibody–IP matrix complex was
incubated with the pre-cleared cell lysate at 4 °C for 12 h. After
incubation the lysate was centrifuged to pellet the IPmatrix. Thematrix
waswashed three timeswith PBS and resuspended in 15 μl of dH2O and
3 μl 6× SDS loading dye. Samples were boiled for 5 min and resolved on
a 10% polyacylamide gel. A Western blot assay was used with PITX2
antibody and HRP conjugated ExactaCruz reagent to detect immuno-
precipitated proteins.
Expression and puriﬁcation of GST-Tbx1 fusion proteins
Tbx1 was PCR ampliﬁed from a cDNA clone as described and ligated
intopGEX6P-2GSTvector (AmershamPharmaciaBiotech, Piscataway,NJ)
(Amendt et al., 1999; Green et al., 2001; Vadlamudi et al., 2005) using
EcoRI and XhoI restriction enzyme sites engineered into the primers
(1049 bp). PITX2 deletion constructs have been previously described
(Amendt et al., 1999). The plasmids were conﬁrmed by DNA sequencing
and transformed into BL21 cells. Protein was isolated as described
(Amendt et al., 1999; Cox et al., 2002). Tbx1 proteins were cleaved from
theGSTmoietyusing80 unitsof PreScissionprotease (PharmaciaBiotech)
per milliliter of Glutathione Sepharose. Cleaved proteins were stored in10% glycerol. Protein concentration was quantitated with Bradford
Reagent (Bio-Rad Laboratories, Hercules, CA). Proteins were examined
by electrophoresis on denaturing SDS–polyacrylamide gels, followed by
Coomassie Blue staining.
GST pull-down assays
Immobilized GST-PITX2A, GST-PITX2A homeodomain only (GST-
PITX2A HD) and GST-PITX2A C173 fusion proteins were prepared as
describedaboveand suspended inbindingbuffer (20 mMHEPESpH7.5,
5% glycerol, 50 mM NaCl, 1 mM EDTA, 1 mM DTT, with or without 1%
milk and 400 μg/ml of ethidium bromide). Puriﬁed bacteria expressed
Tbx1 (200 ng) was added to 15 μg immobilized GST-PITX2A, GST-
PITX2A HD and GST-PITX2A C173 fusion proteins or GST in a total
volume of 100 μl and incubated for 30 min at 4 °C. The beads were
pelleted and washed four times with 200 μl binding buffer. The bound
proteinswere eluted byboiling in SDS-sample buffer and separated on a
10% SDS–polyacrylamide gel. Following SDS gel electrophoresis, the
proteins were transferred to PVDF ﬁlters (Millipore), immunoblotted
and detected using Tbx1 antibody (Zymed) and ECL reagents from
Amersham.
Electrophoretic mobility shift assay (EMSA)
Complementary oligonucleotides containing a PITX2 binding site
within the Dlx2 promoter with ﬂanking partial BamHI ends were
annealed and ﬁlled with Klenow polymerase to generate 32P-labeled
probes for EMSAs as described (Green et al., 2001). Standard binding
assays were performed as previously described (Amendt et al.,
1999b). The bacteria expressed and puriﬁed Tbx1 protein was used
in the assays. The samples were electrophoresed and visualized as
described previously (Green et al., 2001).
Chromatin immunoprecipitation (ChIP) assays
The ChIP assays were performed as previously described using the
ChIP Assay Kit (Upstate) with the following modiﬁcations (Amen et al.,
2007; Diamond et al., 2006). LS-8 cells were fed for 24 h, harvested and
plated in 60 mm dishes. Cells were cross-linked with 1% formaldehyde
for 10 min at 37 °C the next day. The PCR reactions were 5 min at 94 °C,
1 min at 94 °C, 1 min at 60 °C, 1 min at 72 °C×40 cycles and 7 min at
72 °C. Two primers for amplifying the Pitx2 binding site in the p21
promoter are as follows: sense-5′GGATGTCATGTAACCTTGATGAATT3′
and antisense, 5′GCTACATAGCAAGACCACCATCTCAG3′. All the PCR
products were evaluated on a 2% agarose gel in 1× TBE for appropriate
size and conﬁrmed by sequencing. As controls the p21 primers were
used without chromatin, normal rabbit IgG (Santa Cruz) was used
replacing the PITX2 antibody (Capra Science) to reveal non-speciﬁc
immunoprecipitation of the chromatin. An additional control consisted
of primers to another transcription factor binding site in another gene.
Results
Tooth morphogenesis is disrupted in Tbx1−/− mouse embryos
The expression pattern of Tbx1 during tooth development has been
previously reported using in situ probes (Caton et al., 2009; Mitsiadis
et al., 2008; Zoupa et al., 2006).We used the Tbx1-lacZ knock-in allele to
examine Tbx1 expression at later stages using whole mount Tbx1−/+
mouse embryos. Tbx1 (LacZ) expression was observed in the palate
rugae and well as incisor and molar tooth germs at E14.5 and E16.5
(Fig. 1A,B). The mandible was excised from P0 Tbx1−/+ mice to reveal
strong Tbx1 (LacZ) expression in the incisor posterior region (includes
the cervical loop) and molar cusps (Fig. 1C). We also observed strong
Tbx1 expression in the hair follicles (data not shown).
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mutant embryos were analyzed at E14.5, 16.5 and 18.5 for defects in
tooth morphogenesis, as these mice fail to survive past birth (Jerome
and Papaioannou, 2001). At E14.5 there is little difference in the
structure of the incisors and molars of the Tbx1−/−mice compared to
wild type embryos (Fig. 1D). The Tbx1mutant tooth germs are slightly
smaller than wild type at this stage. Thus, Tbx1 does not appear to
affect tooth development at this stage of development.
The E16.5 Tbx1−/− embryos begin to reveal defects in tooth
morphogenesis as the molars are smaller, cusps are not forming and
the pre-ameloblast cell layer is thin compared to wild type (Fig. 2A–D).
The mutant incisor phenotype is more severe at this stage. The incisors
are approximately half the size of wild type incisors and the cervical
loops are less developed (Fig. 2E,F).
A clear defect was observed in the structure of the developingmolar
at E18.5 in the Tbx1−/− mouse (Fig. 2H). Compared to the wild type
(WT)mouse the epitheliumdoes not form the characteristic bulges that
will give rise to molar cusps (Fig. 2H). Furthermore, the epithelial layer
appears thin and undifferentiated in the Tbx1−/− embryos compared to
wild type embryos (Fig. 2H,J). The Tbx1−/−mutant incisors demonstrate
a lack of epithelial cell proliferation and differentiation as seen by the
decrease in epithelial cells in the cervical loop and a deﬁned region of
differentiated epithelial cells or pre-ameloblasts (Fig. 2L). During tooth
development there is a natural developmental gradient of pre-E14.5
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Pre-ameloblast differentiation is defective in the Tbx1−/− mice
To determine if pre-ameloblast differentiation was affected in the
Tbx1−/− mice we stained for amelogenin, a marker for ameloblast
differentiation and required for enamel synthesis. Because Tbx1mutant
mice die at birth we assayed for amelogenin expression at E18 in the
upper incisors as they are developmentally advanced compared to
molars and begin to express amelogenin at this time point. Comparable
wild type and mutant sections were used and IHC staining for
amelogenin revealed expression in the wild type incisors but amelo-
genin was not detected in the mutant incisors (Fig. 3). Thus, the Tbx1
mutant incisors appear to have a defect in ameloblast differentiation
corresponding to reduced amelogenin expression.
Tbx1 regulates epithelial cell proliferation
BrdU labeling was used to determine if decreased epithelial cell
proliferation was causative for the tooth anomalies. Tbx1−/− mutant
andwild type embryos were harvested at E17.5, sectioned and probed6.5
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revealed a decrease in BrdU positive epithelial cells compared to wild
type sections (Fig. 4A–B). A similar defect in cell proliferation was
observed in E17.5 Tbx1−/− mice incisor sections compared to wild
type (Fig. 4C,D). To determine if a proliferation defect occurred at an
early embryonic stage, E14.5 Tbx1−/− mice molar sections did not
reveal a speciﬁc defect in cell proliferation compared to wild type
(Fig. 4F,G). Because Tbx1 is speciﬁcally expressed in the dental
epithelium, proliferation defects were not detected in the mesen-
chyme tissue (Fig. 4E,H).E18.5 WT 
A 
Fig. 3. Amelogenin expression in wild type and Tbx1 null mice—E18.5 Tbx1 null mutant epi
upper incisors from WT embryos are beginning to express amelogenin from the epithelialThe cyclin-dependent kinase inhibitor, p21 is up-regulated in the Tbx1−/−
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To understand the molecular mechanism of decreased epithelial
cell proliferation we focused on p21 gene expression. p21 expression
is associated with non-proliferating cells and is normally down-
regulated during active cell proliferation. p21 is expressed in the
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non-proliferating epithelial cell regions or signaling centers (Thesleff
et al., 2001). IHC staining revealed low p21 expression as expectedE 18.5 Tbx1 null 
B 
thelial cells do not express the ameloblast differentiation marker amelogenin. A) E18.5
cell layer. B) E18.5 Tbx1 null mutants do not express amelogenin at this stage.
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In contrast p21 expression was increased in the E16.5 Tbx1−/−molar
dental epithelium (Fig. 5B). In wild type E18.5 molars minimal p21
expression was observed in the dental epithelium (Fig. 5C). However,
in the Tbx1−/− E18.5 embryos, p21 expression was further increased
throughout the dental epithelium (Fig. 5D). Thus, Tbx1 appears to
repress p21 expression in the normal tooth germ to allow for
epithelial cell proliferation.
Tbx1 represses PITX2 transcriptional activation
To functionally test if PITX2 and/or Tbx1 regulated the p21 promoter
PITX2 and/or Tbx1 were co-transfected with the p21 promoter/
luciferase construct. The 2.4 kb p21 promoter was activated by PITX2A
at 26-fold and Tbx1 minimally activated the p21 promoter at 4-fold
(Fig. 6A). Interestingly, Tbx1 repressed PITX2 activation of the p21promoter. Tbx1 expression vector was titrated from 0.5 to 3.75 μg with
PITX2 co-expression at 2.5 μg. Tbx1 demonstrated a dose response in
attenuating PITX2 transcriptional activation from 26-fold to 4-fold with
increasing concentrations of Tbx1 plasmid (Fig. 6A). At equal concen-
trations of both Tbx1 and PITX2 plasmids, Tbx1 decreases PITX2 activity
4-fold, demonstrating that Tbx1 functionally attenuates PITX2 activa-
tion of the p21 promoter.
Lef-1 can regulate cell proliferation through the activation of cyclin
D1. PITX2A activated the LEF-1 promoter at ~19-fold and Tbx1 does not
independently regulate the LEF-1 promoter (Fig. 6B). Tbx1 repressed
PITX2 transcriptional activation from 19-fold to 12-fold (Fig. 6B).
PITX2A activated the 3.0 kb Pitx2c promoter at ~17-fold and Tbx1 does
not regulate the Pitx2c promoter (Fig. 6C). However, Tbx1 represses
PITX2A activation of its promoter from 17-fold to ~4-fold (Fig. 6C).
These data reveal a combinatorial effect of Tbx1 on both PITX2
expression and transcriptional activity. Where Tbx1 can repress PITX2
E18.5 p21 expression
ep
 mes
C WT 
ep
 mes
D Tbx1-/- 
E16.5 p21 expression
A
B
WT 
Tbx1-/- 
ep
 mes
 mes
ep
Fig. 5. Increased p21 expression in the Tbx1−/− mouse embryo molar. E 16.5 and E18.5 mouse embryo molar sections (sagittal) were incubated with p21 antibody and visualized
using the AEC staining kit. A)Wild type (WT) E16.5 molar section showing low p21 expression in the dental epithelium. B) Tbx1−/− E16.5 molar sections demonstrate an increase in
p21 expression throughout the dental epithelium. C) WT E18.5 molar section revealed low p21 expression. D) Tbx1−/− E18.5 molar sections demonstrate an increase in p21
expression throughout the dental epithelium compared to Tbx1−/− E16.5 molars and E18.5 wild type molars. Ep, epithelium; mes, mesenchyme. These experiments were repeated
more than three times for each embryonic stage and genotype (NN3).
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repress its activation of the p21 promoter during normal tooth
morphogenesis. This new molecular mechanism provides a strong
modulation of PITX2 transcriptional activity.A Vector 
Tbx1
PITX2A 
PITX2A+Tbx1 2.5 µg 
Luc 
p21  
Fold Activation
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Fig. 6. Tbx1 represses PITX2activationof thep21, LEF-1andPitx2cpromoters. A)LS-8oral epith
plasmids or a combination of both and 5 μg of the p21 promoter plasmid. All DNA was dou
transfection efﬁciency all transfections included the SV-40 β-galactosidase reporter (0.5 μg). Th
without expression plasmids andnormalized toβ-galactosidase activity (±SEM from three inde
promoter plasmid (Amenet al., 2007)was used instead of the p21 promoter and 2.5 μg Tbx1 and
plasmids as in panel A. D) Western blot of Tbx1 transfected cell lysates demonstrating Tbx1 a
(80 ng) and Tbx1 protein (80 ng) were incubatedwith a PITX2 DNA binding element (TAATCC)
bind the DNA. Tbx1 (80 ng) was added to PITX2 protein (80 ng) and did not inhibit PITX2 binWestern blot analyses of co-transfected Tbx1 and PITX2 did not
reveal degradation of the Tbx1/PITX2 complex as a possible
mechanism for the repressed PITX2 transcriptional activity
(Fig. 6D). Furthermore, the attenuated PITX2 transcriptional activityTbx1
PITX2A 
D 
PITX2A - + - +
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elial cellswere transfectedwith2.5 μgof PITX2A, and indicatedamounts of Tbx1expression
ble CsCl banded for purity and cells were transfected by electroporation. To control for
e activities are shown as mean-fold activation compared with the p21 promoter plasmid
pendent experiments). B)Transfectionswereperformedas inpanel A except that the LEF-1
Pitx2. C) CHO cellswere transfectedwith the Pitx2c promoter plasmid and the expression
nd PITX2 expression. E) PITX2 DNA binding activity is unaffected by Tbx1. PITX2 protein
as the radioactive probe. PITX2 protein bound to the DNA probe and Tbx1 protein did not
ding to the DNA. The EMSA experiments were analyzed in 8% native polyacrylamide gels.
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Electrophoretic mobility shift assays demonstrate that Tbx1 has no
effect on the DNA binding activity of PITX2 (Fig. 6E).
Pitx2 endogenously regulates p21 expression
We were unable to demonstrate Tbx1 directly repressing p21
expression through various assay systems. Because Pitx2, Tbx1 and p21
are co-expressed in the dental epithelium and enamel knot (Jernvall
et al., 1998; Venugopalan et al., 2008)we asked if Pitx2 could be directly
regulating p21. Analyses of the p21 promoter revealed multiple Pitx2
binding elements (Fig. 7A). ChIP assays using LS-8 cells (oral epithelial
cell line) (Chen et al., 1992) revealed endogenous Pitx2 binding to the
p21 promoter in vivo (Fig. 7B). The Pitx2 antibody immunoprecipitated
the p21 chromatin (Fig. 7B, lane 3), and the input control conﬁrms that
the p21 primers amplify the p21 chromatin (Fig. 7B, lane 4). Rabbit IgG
control did not immunoprecipitate the p21 chromatin (Fig. 7B, lane 5)
and the Pitx2 antibody did not non-speciﬁcally immunoprecipitate
chromatin seen by using control primers to another gene (Fig. 7B,
lane 6). As a control we show that the control primers do amplify the
input chromatin (Fig. 7B, lane 7). These data demonstrate direct DNA
binding of endogenous Pitx2 to the p21 promoter.
To demonstrate endogenous PITX2 activation of p21 expression,
PITX2C transgenic (Tg) mouse embryo ﬁbroblasts (MEF) (Venugopalan
et al., 2008) were analyzed for p21 expression. Wild type MEFs and
PITX2C Tg MEFs were harvested, lysed and probed by Western blot for
p21 expression. Low levels of p21 protein expression were observed in
wild type MEFs, however using PITX2 over-expressing MEFs revealed
increased p21 expression (Fig. 7C). As a loading control the same blot
was probed for GAPDH expression (Fig. 7C). To demonstrate that Tbx1
attenuates Pitx2 transcriptional activation of p21 in LS-8 cells, these cells
were transfected with PITX2A or both PITX2A and Tbx1 and p21
expression observed by Western blot. LS-8 cells endogenously express
p21 (Fig. 7D, lane 1) and transfected PITX2A increased endogenous p21
expression (Fig. 7D, lane 2). However, co-transfection of Tbx1 with
PITX2A revealed a decrease in endogenous p21 expression (Fig. 7D,
lane 3). These data clearly demonstrate that PITX2 endogenously
regulates p21 expression.-1760 bp -1468 bp
GGATTA AAATCC
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+ + + + + + + + 
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Fig. 7. Pitx2 activates p21 expression. A) Schematic of the p21 promoter indicating the Pitx
reveals endogenous Pitx2 binding to the p21 endogenous promoter in the LS-8 oral epithel
antibody ChIP and p21 primers showing Pitx2 binding to the p21 promoter; lane 4, input con
control primers to another transcription factor promoter; lane 7, input control with the contr
PITX2C transgenic MEFs. MEF lysates were prepared and analyzed on aWestern blot probed w
blot was probed for GAPDH expression as a loading control. D) LS-8 cells were transfected
prepared after 24 h and Western blot probed for p21 expression. β-Tubulin served as a loa
probed for endogenous Pitx2 expression by Western blot. β-tubulin served as a loading conWe demonstrated in Fig. 6 that Tbx1 attenuated PITX2 activation of
the mouse Pitx2c promoter. Thus, we asked if endogenous Tbx1
expression regulated endogenous Pitx2 isoform expression. Wild type
MEFs endogenously express Tbx1 (data not shown) andwild typeMEFs
predominantly express the Pitx2a isoform and we are unable to detect
the Pitx2c isoform (Fig. 7E). However, Tbx1 null MEFs have increased
Pitx2a expression but more importantly reveal Pitx2c expression
(Fig. 7E). Tbx1 appears to inhibit Pitx2a activation of the Pitx2c
promoter. The Pitx2a promoter is longer and more complex with
regards to DNA transcription factor binding elements compared to the
internal Pitx2c promoter. Furthermore, we have shown that the Pitx2c
promoter is positively regulated by PITX2A, providing a positive
feedback loop for the continuous expression of Pitx2c. Tbx1 appears to
be a major regulator of Pitx2 isoform expression through its interaction
with Pitx2 and regulation of Pitx2 transcriptional activities.
Tbx1 directly interacts with the PITX2 C-terminal tail
PITX2 acts as a transcriptional activator but can be repressed through
its interaction with other transcription factors (Amen et al., 2008; Berry
et al., 2006). Because PITX2 and Tbx1 are co-expressed during critical
times of craniofacial developmentwe asked if they physically interacted
(Hjalt et al., 2000). Furthermore, a PITX2 and Tbx1 interaction would
provide a mechanism for the modulation of PITX2 transcriptional
activity by Tbx1. The PITX2 and Tbx1 interaction was assayed using a
Tbx1 antibody to immunoprecipitate a PITX2A/Tbx1 complex in
transfected CHO cells. The immunoprecipitation experiments revealed
a PITX2A interaction with Tbx1 (Fig. 8A, lane 4). As controls, empty
vector, PITX2A and Tbx1 transfection alone did not immunoprecipitate
PITX2A. PITX2A expression is shown in transfected CHO cell lysates
(input control) and also seenwhen co-transfectedwith Tbx1. Mock and
Tbx1 input lanes were used as controls with the PITX2A antibody
(Fig. 8A). The transfected PITX2 protein migrates slower in the gel
compared to pure protein due to a myc/his tail on the transfected
protein. Furthermore, CHO cells do not endogenously express Pitx2 as
shown in the mock and Tbx1 transfected cell lysates.
GST pull-down assays were performed using immobilized GST-
PITX2A on Sepharose beads and incubated with puriﬁed Tbx1 proteinp21 
B 
1    2     3     4     5     6     7    8 
-Tubulin 
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Pitx2a 
2 DNA binding elements and location of primers for the ChIP assay. B) The ChIP assay
ial cells. Lane 1, PCR markers; lane 2, p21 primers only without template; lane 3, Pitx2
trol using the p21 primers; lane 5, the IgG control ChIP; lane 6, Pitx2 antibody ChIP and
ol primers; lane 8 PCRmarkers. C)Western blot of p21 expression in wild typeMEFs and
ith p21 antibody and visualized with ECL reagents (GE HealthCare). The sameWestern
with empty vector (lane 1), PITX2A (Lane 2) or PITX2A and Tbx1 (Lane 3) and lysates
ding control. E) Tbx1null MEFs lysates and WT MEFs lysates were cultured and lysates
trol.
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(homeodomain only) and the PITX2 C-terminal proteins were immo-
bilized tomap the Tbx1 interactionwithPITX2A(Fig. 8B). Tbx1bound to
the full-length protein as well as to the PITX2A C173 protein, which
contains only the C-terminus of PITX2 (Fig. 8C). As a control, Tbx1 did
not bind to the PITX2A homeodomain. The PITX2A C-terminus contains
a transcriptional activation domain and protein interaction domain
present in all PITX2 isoforms (A, B, C, and D) (Amendt et al., 1999; Cox
et al., 2002), which contribute to the transcriptional activities of PITX2.
Pitx2 and Tbx1 double heterozygous mice develop an extra premolar-like
tooth
To demonstrate a genetic interaction between Pitx2 and Tbx1, mice
heterozygous (het) for bothgenesweremated andthePitx2−/+/Tbx1−/+
double het mice survived and presented with an extra tooth bud in the
diastema region at P1 (Fig. 9A). At 6 weeks of age themutant mice were
analyzed for teeth phenotypes and revealed an extra functional tooth on
the right side mandible next to the ﬁrst molar in the diastema region
(Fig. 9C). The insert shows an SEMphoto of the extra tooth,without cusp
formation associated with molars (Fig. 9C). X-ray analyses of the
mandible from the double het identiﬁed the extra tooth as having one
root structure unlike a molar (Fig. 9E). The crown of the extra tooth
appears more like a canine than an incisor. These data demonstrate a
dose effect of both Pitx2 and Tbx1 in regulating tooth patterning. Both
genes are co-expressed in thedeveloping dental epitheliumat early time
points and their combined antagonistic interactions may be key
regulators in establishing a gene expression hierarchy required for
normal murine dentition.
Discussion
There are many genetic mutations and syndromes that affect
craniofacial and tooth development. Transcription factors play a major
role in determining the temporal and spatial control and timing of tooth
development. T-box factors are involved in numerous developmental
processes and are essential transcription factors, which interact with
other factors to regulate gene expression. Tbx1 is expressed in the head
mesenchyme, ﬁrst pharyngeal arch, and second heart ﬁeld (Vitelli et al.,
2002; Zhang et al., 2006). Tbx1 demonstrates a restricted pattern ofC 
- PITX2 
A 
PITX2A 
PITX2A HD 
PITX2A C173 
B 
 1     2     3     4     5     6     7     8     9    
Fig. 8. Tbx1 physically interacts with the PITX2 C-terminal tail. A) Immunoprecipitation ass
Western blot using the PITX2 Ab. The PITX2-Tbx1 complex was immunoprecipitated from
co-transfected with Tbx1 (lane 8). As a control puriﬁed PITX2 protein was run on the gel (lan
the transfected protein due to a myc/his tag on the transfected protein. The immunoprecipit
and Western blotting was done using PITX2 antibody. B) Schematic of the PITX2 deletion c
homeodomain; OAR, 14 amino acid conserved domain (protein interaction domain). C) GS
Tbx1 binds to the full-length PITX2 protein and the C-terminal peptide (PITX2A C173). As
detected by Western blot using the Tbx1 antibody.expression during craniofacial development to epithelial tissues of the
tooth germs, palatal shelves, and hair follicles (Zoupa et al., 2006). TBX1
mutations are associated with DiGeorge syndrome (DGS) or velocar-
diofacial syndrome and is deleted in 22q11 deletion syndrome (Yagi
et al., 2003). The craniofacial anomalies in patients (e.g. hypodontia,
cleft palate, facial dysmorphogenesis and ear defects) correlate well
with Tbx1 expression in mice (Scambler, 2000).
Tbx1 regulates later stages of tooth development
Previous reports using in situ hybridization assays demonstrated
Tbx1 expression starting at E11.5 in the dental placode (Caton et al.,
2009; Mitsiadis et al., 2008; Zoupa et al., 2006). The Tbx1mice carry the
lacZ knock-in allele and using LacZ staining we observe a similar
expression pattern. We show that Tbx1 is expressed in the palate rugae
and palate midline. Because the dental defects do not appear until after
E14.5 this suggests that Tbx1 affects the later stages of dental
development. The E16.5 and E18.5 Tbx1 null embryos reveal incisor
andmolar anomalies including severely regressed growth of both types
of tooth germs and apparent epithelial cell proliferation defects. These
data indicate a role for Tbx1 in cell proliferation through possible
regulation of signaling factors, transcription factors or cell cycle control
genes.
Tbx1 and signaling factors during development
There is a gradient of LacZ expression at the cap stage (E14.5) with
Tbx1 expression predominately observed in the cervical loop and
enamel knot regions, with less expression in the inner enamel
epithelium throughout the tooth germ (data not shown). These data
suggest that Tbx1 expression is highest in the proliferating cells of the
cervical loop, with a decrease in expression as these cells differentiate
into the pre-ameloblasts, which will give rise to enamel. In contrast,
Tbx1 expression was also localized to the enamel knot (EK) structures
(primary and secondary knots), which are clusters of non-dividing
epithelial cells (data not shown). The expression of Tbx1 in the EK may
represent its role in regulating the expressionof signaling factors suchas
ﬁbroblast growth factors (FGFs) that are required to stimulate
proliferation of adjacent mesenchymal and epithelial cells (Thesleff
et al., 2001). Tbx1 has been shown to regulate FGFs in the pharyngealTbx1 
HD OAR 
Tbx1 binding
+++ 
-  
+++ 
ay using the Tbx1 Ab to immunoprecipitate the Tbx1-PITX2 complex and probed on a
co-transfected lysates (lane 4). Transfected PITX2 input is shown in lane 6 and when
e 9). The puriﬁed bacterial expressed PITX2 protein migrates slightly faster compared to
ated complex was resolved on a 10% polyacrylamide gel and transferred to a PVDF ﬁlter
onstructs used to map the Tbx1 interaction region by GST-pull down experiments. HD,
T-pull down assay using immobilized GST-PITX2 constructs and puriﬁed Tbx1 protein.
a control Tbx1 did not bind to the PITX2 HD (homeodomain). The bound protein was
Fig. 9. Tbx1−/+/Pitx2−/+ double het mice development an extra canine-like tooth—The Pitx2+/−mouse crossed with a Tbx1+/−mouse results in the growth of an extra tooth in the
diastema region in front of the ﬁrst molar. A) HE staining of P1 Pitx2+/−Tbx1+/−mouse showing the early stage of a tooth structure. B) HE staining of P1WTmouse. C) A 6-week-old
Pitx2+/−Tbx1+/−mouse with an extra tooth in front of the ﬁrst molar in the lower jaw. Also shown with SEM image D) A 6-week-old WT mouse. E) X-ray picture of the 6-week-old
Pitx2+/−Tbx1+/− mouse molars showing only one root on extra tooth. F) X-ray picture of 6 week WT mouse molars.
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Tbx1 may also be regulating Fgf signaling in the cervical loop. A recent
report using bead implantation experiments has suggested that Fgf
activates Tbx1 expression in the dental epithelium (Mitsiadis et al.,
2008). Thus, there may be a regulatory loop between Tbx1 and Fgf
expression during tooth development in maintaining epithelial cell
proliferation.At P0 Tbx1expression is highest in the incisor cervical loop,
a structure containing progenitor cells that allow for the continued
growth of themouse incisor. At this stage high levels of Tbx1 expression
are also observed in themolar cusps derived from the secondary enamel
knots. Tbx1 expression at later stages in the cusps themselves supports a
role for Tbx1 in epithelial cell proliferation required for cusp formation.
Epithelial cell proliferation is markedly decreased in the Tbx1−/− mouse
tooth germ
In the Tbx1−/− mouse the dental epithelium layer is thinner with
decreased amounts of cells and BrdU labeling demonstrated a speciﬁc
defect in epithelial proliferation throughout the molar epithelium and
speciﬁcally in the cervical loop. Furthermore, the molar structure of the
mutant mouse lacks the characteristic bulges that give rise to the molar
cusps. Thus, the cusp size, which is one factor of cusp patterning, is
determined solely by the epithelium (Cai et al., 2007). During molar
development Tbx1 appears to play a major role in cusp size, but not
patterning. The incisors of the Tbx1−/− mutant mouse are formed but
due to the early lethality of the mice it is not possible to study their
mature erupted structure. The cervical loop on the lingual side clearlyrevealed less progenitor cells and BrdU labeling demonstrated a speciﬁc
defect in proliferation of the epithelial cells.
p21 expression is up-regulated in the Tbx1−/− mouse dental epithelium
The cyclin-dependent kinase inhibitor, p21 is involved in the
differentiation of the enamel knot, where it is highly expressed during
tooth development (Jernvall et al., 1998). BMP-4 can induce p21
expression and p21 is associated with apoptosis of the enamel knot,
linking it to the transient nature of the enamel knot structure (Jernvall
et al., 1998). p21 can also be induced by transforming growth factor-β
(TGF-β) and because TGF-β is expressed in the bud stage tooth
epithelium it may also be a candidate to regulate p21 expression
(Bloch-Zupan et al., 1998; Datto et al., 1995). At later stages beyond the
cap stage (E14.5) p21 expression is decreased in the dental epithelium
and at E18.5 we detect low p21 protein expression in the epithelium.
However, in the Tbx1−/− mouse we observed p21 expression
throughout the dental epithelium, including the cervical loop region.
Thus, Tbx1 appears to be facilitating cell proliferation through the
repression of p21 expression.
Tbx1 interacts with and attenuates PITX2 transcriptional activity
We have shown that Tbx1 interacts with the C-terminal tail of PITX2
and this interaction inhibits PITX2 transcriptional activation of the p21,
LEF-1 and Pitx2c promoters. Both Lef-1 and Pitx2 are expressed in the
dental epithelium and the enamel knot and are also associated with cell
Tbx1 
Epithelial Cell Proliferation 
Fgf signaling 
Pitx2  
p21 
cell cycle control
Fig. 10. Function of Tbx1 during tooth development. Tbx1 regulates cell proliferation in
the cervical loop either by activating the Fgf signaling pathway or by attenuating PITX2
activation of p21 expression.
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is required for cell proliferation its repression of PITX2 transcriptional
activity appears to modulate a cell differentiation pathway. We have
shown that PITX2 activates a variety of genes regulating dental epithelial
cell differentiation (Amen et al., 2007; Cox et al., 2002; Espinoza et al.,
2005;Greenet al., 2001;Vadlamudi et al., 2005;Venugopalanet al., 2008).
A recent study showed that β-catenin over-expression increased Pitx2
and p21 expression in the dental epithelium (Wang et al., 2009). These
data suggest that Pitx2, which directly interacts with β-catenin could be
regulating p21 expression. Our demonstration that PITX2 activates the
p21 promoter reveals a new transcriptionalmechanism for the regulation
cell differentiation. During normal tooth development Tbx1 represses
Pitx2 transcriptional activation of the Pitx2c promoter, which decreases
Pitx2 expression. Tbx1 null MEFs revealed an increase in Pitx2 expression
however, Tbx1 does not directly regulate the Pitx2 promoter but interacts
with the Pitx2 protein to attenuate Pitx2 transcriptional activity and the
Pitx2 positive feedback loop regulating the Pitx2c promoter. Thus,
decreased Pitx2 expression coupled with the ability of Tbx1 to repress
PITX2 activation of p21 would signiﬁcantly down-regulate p21 expres-
sion. Tbx1 attenuation of PITX2 transcriptional activation may promote
cell proliferation by decreasing p21 levels. These data reveal for the ﬁrst
time a role for Tbx1 in cell proliferation through its ability to indirectly
regulate the p21 gene, which is associated with cell cycle arrest.
Furthermore, we demonstrate a novel molecular function for Pitx2 in its
ability to activate p21, which would repress cell proliferation.
Tbx1 and Pitx2 control tooth patterning
To understand the combinatorial activities of Tbx1 and Pitx2 in
controlling tooth morphogenesis the Tbx1−/+/Pitx2−/+ double hetero-
zygous mice were analyzed for tooth anomalies. Null mutants for both
genes severely affect tooth development, however Pitx2 null mice
presentwith tooth arrest at early stages (Lu et al., 1999). Both genes are
expressed early during the tooth development program and speciﬁcally
in the dental epithelium. The double het mutant presents with an extra
tooth in the diastema region of themousemandible and the extra tooth
appears similar to a canine. Interestingly, we have observed an extra
tooth on either side of themandible but not both.We speculate that the
decreased dose of both factors relieves an inhibitory mechanism by
signaling factors or transcription factors to stimulate tooth formation.
More experiments are required to understand the molecular mechan-
isms of decreased Tbx1 and Pitx2 expression on extra tooth formation
and the type of tooth produced in the diastema region. However, these
experiments demonstrate a genetic interaction between Tbx1 and Pitx2
in regulating tooth development.
Function of Tbx1 in the dental epithelium
We propose a mechanism for the function of Tbx1 during tooth
development based on our studies and those of other investigators(Fig. 10). Tbx1 may enhance cell proliferation in the cervical loop by
directly activating factors associated with cell cycle progression or
through its activation of Fgf signaling in the dental epithelium. In this
report we have identiﬁed a new molecular mechanism for dental
epithelial cell proliferation and differentiation. PITX2 activates many
genes involved in dental epithelial cell differentiation and prolifera-
tion and repression by Tbx1 may inhibit proliferation. Therefore,
PITX2 activates p21 expression suggesting a new mechanism where
Tbx1 promotes cell proliferation through its ability to repress PITX2
activation of p21 expression. These data reveal a possible molecular
mechanism for hypodontia in the DGS phenotype.
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